EUVIMEDEUVIMED entdecken
Crossref

Region‐ and Time‐Dependent Gene Expression Responses to Siponimod, Atorvastatin and Methylprednisolone After Spinal Cord Injury

Katarina Kiss Bimbova iD, Alexandra Kisucka iD, Tomas Kuruc iD, Maria Ileninova iD, Karolina Kucharova iD, Lenka Ihnatova iD, Maria Bacova iD, Martina Magurova iD, Nadezda Lukacova iD

European Journal of Neuroscience · 2026-11 · 64 (9)

DOI: 10.1111/ejn.70750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, online erschienen am 11.11.2026. Verfasst von Katarina Kiss Bimbova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurobiology of Biomedical Research Center, Slovak Academy of Sciences, Košice, Slovakia. Hauptthemen laut MEDLINE: Atorvastatin, Spinal Cord Injuries, Azetidines, Methylprednisolone. Die Arbeit nennt 94 Literaturangaben. Gefördert von: Slovak Research and Development Agency, Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences, Bilateral Mobility Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic spinal cord injury (SCI) triggers a secondary injury cascade in which microglia, infiltrating macrophages and astrocytes influence tissue degeneration and repair. These responses are dynamic and region‐dependent, yet the comparative effects of anti‐inflammatory therapies remain unclear. We evaluated siponimod, atorvastatin and methylprednisolone after Th9 compression injury in rats. Gene expression was assessed by quantitative RT‐PCR in rostral, lesion and caudal spinal cord segments at 2 and 6 weeks postinjury. At 2 weeks, all treatments reduced microglia/macrophage‐associated and inflammatory transcripts, particularly rostrally, as shown by reduced Iba1 and iNOS expression. Siponimod and atorvastatin also decreased IL‐1β rostrally, whereas siponimod was associated with region‐specific increases in inflammatory markers at the lesion site and caudally. Siponimod most consistently increased microglia/macrophage‐associated transcripts linked to immunoregulatory and reparative responses caudally, including IL1rn, TGF‐β, SOCS3 and IL4Rα. It also reduced selected inflammatory astrocyte‐associated markers and increased transcripts linked to repair‐related processes, while atorvastatin and methylprednisolone showed mixed effects. At 6 weeks, none of the treatments consistently suppressed pro‐inflammatory microglia/macrophage‐associated markers. Siponimod was associated with elevated transcripts linked to immunoregulatory and repair‐related processes, together with region‐dependent increases in inflammatory markers. Astrocyte‐associated reactivity markers were largely normalised, whereas remodelling‐associated transcripts were altered. Treatments induced modest changes in neuronal/axonal and myelin‐associated transcripts, predominantly rostrally, without significant functional improvement. Overall, these interventions differentially modulated microglia/macrophage‐ and astrocyte‐associated gene expression, with siponimod producing the broadest, but mixed and region‐dependent, gene‐expression pattern. These findings highlight the regional and stage‐dependent complexity of glial and inflammatory gene expression after pharmacological treatment of SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtorvastatinSpinal Cord InjuriesAzetidinesMethylprednisoloneAnti-Inflammatory AgentsGene ExpressionAnimalsRatsMicrogliaMaleMacrophagesAstrocytesRats, Sprague-DawleyBenzyl Compounds

Stichwörter der Autor:innen

astrocytesclinically approved anti‐inflammatory drugsmicroglia/macrophagesrostro‐caudal extentspinal cord compression

Substanzen

AtorvastatinAzetidinesMethylprednisolonesiponimodAnti-Inflammatory AgentsBenzyl Compounds

Autor:innen und Institutionen

  • Institute of Neurobiology of Biomedical Research Center, Slovak Academy of Sciences, Košice, Slovakia.

ORCID-Profile: Katarina Kiss Bimbova, Alexandra Kisucka, Tomas Kuruc, Maria Ileninova, Karolina Kucharova, Lenka Ihnatova, Maria Bacova, Martina Magurova, Nadezda Lukacova

Förderung

  • Slovak Research and Development Agency
  • Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences
  • Bilateral Mobility Project
  • Agentúra na Podporu Výskumu a Vývoja

Zitieren

APA

Bimbova, K. K., Kisucka, A., Kuruc, T., Ileninova, M., Kucharova, K., Ihnatova, L., Bacova, M., Magurova, M., & Lukacova, N. (2026). Region‐ and Time‐Dependent Gene Expression Responses to Siponimod, Atorvastatin and Methylprednisolone After Spinal Cord Injury. European Journal of Neuroscience, 64(9). https://doi.org/10.1111/ejn.70750

Vancouver

Bimbova KK, Kisucka A, Kuruc T, Ileninova M, Kucharova K, Ihnatova L, et al. Region‐ and Time‐Dependent Gene Expression Responses to Siponimod, Atorvastatin and Methylprednisolone After Spinal Cord Injury. European Journal of Neuroscience. 2026;64(9). doi:10.1111/ejn.70750

BibTeX
@article{Bimbova2026,
  author = {Bimbova, Katarina Kiss and Kisucka, Alexandra and Kuruc, Tomas and Ileninova, Maria and Kucharova, Karolina and Ihnatova, Lenka and Bacova, Maria and Magurova, Martina and Lukacova, Nadezda},
  title = {Region‐ and Time‐Dependent Gene Expression Responses to Siponimod, Atorvastatin and Methylprednisolone After Spinal Cord Injury},
  journal = {European Journal of Neuroscience},
  year = {2026},
  volume = {64},
  number = {9},
  doi = {10.1111/ejn.70750}
}
Kostenlos starten →